WO2003088898A3 - Compositions and methods for the diagnosis and treatment of tumor - Google Patents

Compositions and methods for the diagnosis and treatment of tumor Download PDF

Info

Publication number
WO2003088898A3
WO2003088898A3 PCT/US2002/012206 US0212206W WO03088898A3 WO 2003088898 A3 WO2003088898 A3 WO 2003088898A3 US 0212206 W US0212206 W US 0212206W WO 03088898 A3 WO03088898 A3 WO 03088898A3
Authority
WO
WIPO (PCT)
Prior art keywords
compositions
tumor
diagnosis
treatment
methods
Prior art date
Application number
PCT/US2002/012206
Other languages
French (fr)
Other versions
WO2003088898A2 (en
Inventor
Audrey Goddard
Austin L Gurney
Paul Polakis
Victoria Smith
William I Wood
Thomas D Wu
Zemin Zhang
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Priority to PCT/US2002/012206 priority Critical patent/WO2003088898A2/en
Priority to EP02723890A priority patent/EP1494709A4/en
Priority to CA002481085A priority patent/CA2481085A1/en
Priority to KR10-2004-7016573A priority patent/KR20040111525A/en
Priority to JP2003585651A priority patent/JP2005523311A/en
Priority to AU2002254651A priority patent/AU2002254651A1/en
Priority to MXPA04010091A priority patent/MXPA04010091A/en
Publication of WO2003088898A2 publication Critical patent/WO2003088898A2/en
Publication of WO2003088898A3 publication Critical patent/WO2003088898A3/en
Priority to US10/989,826 priority patent/US20050238650A1/en
Priority to US12/079,893 priority patent/US20090053226A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The present invention is directed to compositions of matter useful for the diagnosis and treatment of tumor in mammals and to methods of using those compositions of matter for the same.
PCT/US2002/012206 2001-10-19 2002-04-17 Compositions and methods for the diagnosis and treatment of tumor WO2003088898A2 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
PCT/US2002/012206 WO2003088898A2 (en) 2002-04-17 2002-04-17 Compositions and methods for the diagnosis and treatment of tumor
EP02723890A EP1494709A4 (en) 2002-04-17 2002-04-17 Compositions and methods for the diagnosis and treatment of tumor
CA002481085A CA2481085A1 (en) 2002-04-17 2002-04-17 Compositions and methods for the diagnosis and treatment of tumor
KR10-2004-7016573A KR20040111525A (en) 2002-04-17 2002-04-17 Compositions and Methods for the Diagnosis and Treatment of Tumor
JP2003585651A JP2005523311A (en) 2002-04-17 2002-04-17 Compositions and methods for tumor diagnosis and treatment
AU2002254651A AU2002254651A1 (en) 2002-04-17 2002-04-17 Compositions and methods for the diagnosis and treatment of tumor
MXPA04010091A MXPA04010091A (en) 2002-04-17 2002-04-17 Compositions and methods for the diagnosis and treatment of tumor.
US10/989,826 US20050238650A1 (en) 2002-04-17 2004-11-16 Compositions and methods for the treatment of tumor of hematopoietic origin
US12/079,893 US20090053226A1 (en) 2001-10-19 2008-03-27 Compositions and methods for the treatment of tumor of hematopoietic origin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2002/012206 WO2003088898A2 (en) 2002-04-17 2002-04-17 Compositions and methods for the diagnosis and treatment of tumor

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US10/125,166 Continuation-In-Part US20030039648A1 (en) 1997-10-28 2002-04-17 Compositions and methods for the diagnosis and treatment of tumor

Publications (2)

Publication Number Publication Date
WO2003088898A2 WO2003088898A2 (en) 2003-10-30
WO2003088898A3 true WO2003088898A3 (en) 2004-09-16

Family

ID=29247990

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2002/012206 WO2003088898A2 (en) 2001-10-19 2002-04-17 Compositions and methods for the diagnosis and treatment of tumor

Country Status (7)

Country Link
EP (1) EP1494709A4 (en)
JP (1) JP2005523311A (en)
KR (1) KR20040111525A (en)
AU (1) AU2002254651A1 (en)
CA (1) CA2481085A1 (en)
MX (1) MXPA04010091A (en)
WO (1) WO2003088898A2 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6294663B1 (en) * 1999-03-03 2001-09-25 The Board Of Trustees Of The University Of Arkansas Transmembrane serine protease overexpressed in ovarian carcinoma and uses thereof
US6635468B2 (en) * 1997-09-17 2003-10-21 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1252300B1 (en) * 2000-02-03 2011-01-19 Dendreon Corporation Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon
AU6802801A (en) * 2000-03-01 2001-09-24 Genentech Inc Secreted and transmembrane polypeptides and nucleic acids encoding the same
WO2001083781A2 (en) * 2000-04-28 2001-11-08 Millennium Pharmaceuticals, Inc. 14094, a novel human trypsin family member and uses thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6635468B2 (en) * 1997-09-17 2003-10-21 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US6294663B1 (en) * 1999-03-03 2001-09-25 The Board Of Trustees Of The University Of Arkansas Transmembrane serine protease overexpressed in ovarian carcinoma and uses thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP1494709A4 *

Also Published As

Publication number Publication date
KR20040111525A (en) 2004-12-31
WO2003088898A2 (en) 2003-10-30
CA2481085A1 (en) 2003-10-30
MXPA04010091A (en) 2004-12-13
JP2005523311A (en) 2005-08-04
AU2002254651A1 (en) 2003-11-03
EP1494709A4 (en) 2006-06-28
EP1494709A2 (en) 2005-01-12

Similar Documents

Publication Publication Date Title
WO2003088808A3 (en) Compositions and methods for the diagnosis and treatment of tumor
WO2003024392A3 (en) Compositions and methods for the diagnosis and treatment of tumor
WO2003000113A3 (en) Compositions and methods for the diagnosis and treatment of tumor
EP1445317A3 (en) Compositions and methods for the diagnosis and treatment of tumor
WO2006029183A3 (en) Compositions and methods for the diagnosis and treatment of tumor
MXPA05005107A (en) Compositions and methods for the diagnosis and treatment of tumor.
WO2006110760A3 (en) Compositions and methods for the diagnosis and treatment of tumor
WO2007001851A3 (en) Compositions and methods for the diagnosis and treatment of tumor
WO2004112829A3 (en) Compositions and methods for the diagnosis and treatment of tumors of glial origin
EP2067472A8 (en) Compositions and methods for the diagnosis and treatment of tumor
WO2004030615A8 (en) Compositions and methods for the diagnosis and treatment of tumor
WO2004016225A8 (en) Compositions and methods for the diagnosis and treatment of tumor
WO2002016581A3 (en) Compositions and methods for the diagnosis and treatment of tumor
EP1572091A3 (en) Compositions and methods for the diagnosis and treatment of tumor
WO2005049075A3 (en) Compositions and methods for the treatment of tumor of hematopoietic origin
WO2004024063A3 (en) Compositions and methods for the diagnosis and treatment of tumor
AU2003290605A1 (en) Compositions and methods for the diagnosis and treatment of sepsis
WO2005063299A3 (en) Compositions and methods for the treatment of tumor of hematopoietic origin
WO2002016602A3 (en) Compositions and methods for the diagnosis and treatment of tumor
WO2005003154A8 (en) Compositions and methods for the diagnosis and treatment of tumor
WO2004096124A3 (en) Compositions and methods for the diagnosis and treatment of tumor
WO2006014335A3 (en) Compositions and methods for treatment of non-hodgkin’s lymphoma
MXPA05008293A (en) Compositions and methods for the diagnosis and treatment of tumor.
WO2004019857A3 (en) Achaete-scute like-2 polypeptides and encoding nucleic acids and methods for the diagnosis and treatment of tumor
WO2006081272A3 (en) Compositions and methods for the diagnosis and treatment of tumor

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2002254651

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2481085

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2004/08159

Country of ref document: ZA

Ref document number: 200408159

Country of ref document: ZA

WWE Wipo information: entry into national phase

Ref document number: 2002723890

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 535924

Country of ref document: NZ

WWE Wipo information: entry into national phase

Ref document number: PA/a/2004/010091

Country of ref document: MX

WWE Wipo information: entry into national phase

Ref document number: 1020047016573

Country of ref document: KR

WWE Wipo information: entry into national phase

Ref document number: 2003585651

Country of ref document: JP

WWP Wipo information: published in national office

Ref document number: 1020047016573

Country of ref document: KR

WWP Wipo information: published in national office

Ref document number: 2002723890

Country of ref document: EP